Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Intangibles (2016 - 2023)

Altimmune (ALT) has disclosed Intangibles for 9 consecutive years, with $12.4 million as the latest value for Q3 2023.

  • On a quarterly basis, Intangibles changed 0.0% to $12.4 million in Q3 2023 year-over-year; TTM through Sep 2023 was $12.4 million, a 0.0% change, with the full-year FY2022 number at $12.4 million, changed 0.0% from a year prior.
  • Intangibles was $12.4 million for Q3 2023 at Altimmune, roughly flat from $12.4 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $14.4 million in Q3 2019 to a low of $12.4 million in Q4 2021.
  • A 5-year average of $12.9 million and a median of $12.4 million in 2021 define the central range for Intangibles.
  • Peak YoY movement for Intangibles: plummeted 65.4% in 2019, then grew 1.03% in 2020.
  • Altimmune's Intangibles stood at $13.5 million in 2019, then rose by 1.03% to $13.6 million in 2020, then dropped by 8.61% to $12.4 million in 2021, then changed by 0.0% to $12.4 million in 2022, then changed by 0.0% to $12.4 million in 2023.
  • Per Business Quant, the three most recent readings for ALT's Intangibles are $12.4 million (Q3 2023), $12.4 million (Q2 2023), and $12.4 million (Q1 2023).